Chondronectin
MONDO:0007323
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
MONDO disease family
Recruiting studies by city
Trial status
Trial phase
Study start year
Investigated drug interventions
Chondronectin
Chondronectin is a high molecular weight collagen matrix protein (~180 kDa), or also known as a glycoprotein, and is most commonly found in human synovial fluid. It is mainly responsible for binding chondrocytes and collagen II substrates together in the extracellular matrix (ECM). Chondronectin is characterized as a trimeric protein, that is linked with disulfide bonds. It also has been noted to appear compact and globular in nature. Chondronectin is responsible for helping anchor chondrocytes, bearing mechanical forces and even maintaining homeostasis on a physiological level. Chondronectin works within tissue, where it joins other proteins to build a strong but flexible framework. This structure helps keep joints stable during movement and repeated pressure. Without adhesive matrix proteins like chondronectin, cartilage tissue would have a harder time handling everyday mechanical stress. Chondronectin acts as a strong binding protein inside the body's joints. It helps attach important cartilage cells directly to tough collagen fibers. These cells main responsibility is maintaining healthy cartilage tissue. This protein helps the surrounding tissue structure stay firm and stable while keeping the cartilage properly organized. Without this important connection, the framework of the joins could gradually lose stability. The protein has a three part molecular shape that helps keep it structurally stable. It remains strong while interacting with nearby matrix tissues and surrounding support components. This specialized structure helps cartilage handle repeated pressure and...
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.